Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate

NCT00913458 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00913458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2012
Enrollment
306 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

active rheumatoid arthritis, arthritis, rheumatoid, rheumatoid arthritis